PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025
Rhea-AI Summary
PacBio (NASDAQ: PACB), a biotechnology company, has scheduled its second quarter 2025 financial results conference call for Thursday, August 7, 2025, at 5:00 PM Eastern Time (2:00 PM Pacific Time). The earnings call will be accessible through a webcast on the company's investor relations website.
Participants can join via webcast or dial in using toll-free (1-888-349-0136) or international (1-412-317-0459) numbers. Those choosing to dial in are advised to join ten minutes before the start time.
Positive
- None.
Negative
- None.
News Market Reaction 27 Alerts
On the day this news was published, PACB gained 11.72%, reflecting a significant positive market reaction. Argus tracked a peak move of +11.0% during that session. Our momentum scanner triggered 27 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $51M to the company's valuation, bringing the market cap to $486M at that time.
Data tracked by StockTitan Argus on the day of publication.
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, 2025, at 5:00 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, August 7, 2025, at 5:00 pm ET (2:00 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q2 Earnings Call.”
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When will PacBio (NASDAQ: PACB) report Q2 2025 earnings?
How can investors access PacBio's Q2 2025 earnings call?
What time should investors dial in for PacBio's Q2 earnings call?
Where can I find the replay of PacBio's Q2 2025 earnings call?
